• 1
    Marsh K, Forster D, Waruiru C et al. Indicators of life-threatening malaria in African children. N Engl J Med 1995; 332: 13991404.
  • 2
    Waller D, Krishna S, Crawley J et al. Clinical features and outcome of severe malaria in Gambian children. Clin Infect Dis 1995; 21: 577587.
  • 3
    Taylor TE, Borgstein A, Molyneux ME. Acid-base status in paediatric Plasmodium falciparum malaria. Q J Med 1993; 86: 99109.
  • 4
    Kildeberg P. Metabolic acidosis in infantile gastroenteritis. Acta Paedtr Scand 1965; 54: 155167.
  • 5
    Murphy SA, Mberu E, Muhia D et al. The disposition of intramuscular artemether in children with cerebral malaria: a preliminary study. Trans R Soc Trop Med Hyg 1997; 91: 331334.
  • 6
    Molyneux ME, Taylor TE, Wirima JJ et al. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med 1989; 71: 441459.
  • 7
    Newton CR, Chokwe T, Schellenberg JA et al. Coma scales for children with severe falciparum malaria. Trans R Soc Trop Med Hyg 1997; 91: 161165.
  • 8
    Winstanley P, Newton C, Watkins W et al. Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: the importance of unbound quinine concentration. Trans R Soc Trop Med Hyg 1993; 87: 201206.
  • 9
    Newton CR, Kirkham FJ, Winstanley PA et al. Intracranial pressure in African children with cerebral malaria. Lancet 1991; 337: 573576.
  • 10
    English M, Waruiru C, Marsh K. Transfusion for respiratory distress in life-threatening childhood malaria. Am J Trop Med Hyg 1996; 55: 525530.
  • 11
    English M, Waruiru C, Amukoye E et al. Deep breathing in children with severe malaria: indicator of metabolic acidosis and poor outcome. Am J Trop Med Hyg 1996; 55: 521524.
  • 12
    Mohamed SS, Khalid SA, Ward SA et al. Simultaneous determination of artemether and its major metabolite dihydroartemisinin in plasma by gas chromatography-mass spectrometry-selected ion monitoring. J Chromatogr B Biomed Sci Appl 1999; 731: 251260.
  • 13
    Altman D, Machin D, Bryant T, Gardner MJ. Statistics with confidence, 2nd edn. Bristol: BMJ Books, 2000.
  • 14
    Beal S, Boeckman A, Sheiner L. NONMEM user's guide, Parts I–IV. San Francisco: University of California, 1998.
  • 15
    Karbwang J, Na-Bangchang K, Congpuong K et al. Pharmacokinetics and bioavailability of oral and intramuscular artemether. Eur J Clin Pharmacol 1997; 52: 307310.
  • 16
    Colussi D, Parisot C, Legay F et al. Binding of artemether and lumefantrine to plasma proteins and erythrocytes. Eur J Pharm Sci 1999; 9: 916.
  • 17
    Lefevre G, Carpenter P, Souppart C et al. Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects. Br J Clin Pharmacol 2002; 54: 485492.
  • 18
    Alin M, Bjorkman A, Ashton M. In vitro activity of artemisinin, its derivatives, and pyronaridine against different strains of Plasmodium falciparum. Trans R Soc Trop Med Hyg 1990; 84: 635637.
  • 19
    Murphy S, Watkins WM, Bray PG et al. Parasite viability during treatment of severe falciparum malaria: differential effects of artemether and quinine. Am J Trop Med Hyg 1995; 53: 303305.
  • 20
    Teja-Isavadharm P, Nosten F, Kyle DE et al. Comparative bioavailability of oral, rectal, and intramuscular artemether in healthy subjects: use of simultaneous measurement by high performance liquid chromatography and bioassay. Br J Clin Pharmacol 1996; 42: 599604.
  • 21
    Murphy S, English M, Waruiru C et al. An open randomised trial of artemether versus quinine in the treatment of cerebral malaria in African children. Trans R Soc Trop Med Hyg 1996; 90: 298301.
  • 22
    McIntosh H, Olliaro P. Artemisinin derivatives for the treatment of malaria (Cochrane Review). The Cochrane, Issue I. Oxford: 2003.
  • 23
    Ilett KF, Batty KT, Powell SM et al. The pharmacokinetic properties of intramuscular artesunate and rectal dihydroartemisinin in uncomplicated falciparum malaria. Br J Clin Pharmacol 2002; 53: 2330.